Emergent BioSolutions Inc. (NYSE:EBS) stock rose in Friday premarket trading.On Thursday, New York Attorney General Letitia James sued former chief executive Robert G. Kramer over alleged insider trading.James said Kramer used nonpublic information while setting up sales of Emergent stock.The state also announced a settlement with Emergent over approval of the trading plan.Settlement TermsThe company agreed to pay $900,000 in penalties to New York.Emergent also agreed to strengthen executive stock-trading c ...